Amgen Inc

AI Summary

Amgen discovers, develops, manufactures, and delivers prescription medicines for serious illnesses including rheumatoid arthritis (Enbrel), high cholesterol (Repatha), osteoporosis (Prolia, Evenity), cancer (Blincyto, Kyprolis, Vectibix), and rare diseases like thyroid eye disease (Tepezza) [Yahoo Finance]. The company sells through doctors' offices, hospitals, dialysis centers, and pharmacies, primarily via pharmaceutical wholesalers [Yahoo Finance].

Amgen is the world's largest independent biotech company, developing and selling medicines for cancer, autoimmune diseases, osteoporosis, and rare conditions [Yahoo Finance]. The company generates $36.7B in annual revenue with strong margins, but faces serious safety concerns around its drug Tavneos, which has been linked to 20 deaths and 22 liver injuries in Japan [Seeking Alpha]. Recent leadership changes include the retirement of CFO Peter Griffith, who will be replaced by returning veteran Thomas Dittrich [Yahoo Finance].

Amgen is financially healthy with strong cash generation and reasonable leverage, earning a 7.4/10 health score [Yahoo Finance].

Recent News

• AMGEN ANNOUNCES RETIREMENT OF CHIEF FINANCIAL OFFICER PETER GRIFFITH

  Yahoo Finance· 2026-05-19

• Amgen (AMGN) Gets Price Target Cut at Piper Sandler Despite Long-Term Growth Optimism

  Yahoo Finance· 2026-05-18

• Middle East and Africa Wearable Injectors Market Trends and Forecast Report 2026-2035 Featuring Amgen, BD, Biocon, Gerresheimer, Insulet, J&J, Medtronic, Roche, West Pharmaceutical, Ypsomed

  Yahoo Finance· 2026-05-18

• Amgen Japanese Partner Urges Caution On Tavneos Use

  Yahoo Finance· 2026-05-18

• Is It Time To Reassess Amgen (AMGN) After Strong Multi Year Share Price Gains

  Simply Wall St· 2026-05-15

• Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

  Zacks· 2026-05-15